881 patents currently held
28 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
134
Ending by 2030
Nov 2026
Next term end
452
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2027 · High confidence
Also notable
Ends Sep 2031 · High confidence
Also notable
Ends Mar 2033 · Medium confidence
Management of pending medication orders
US 9,427,520
Cited by 300 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2027.
Displaying Visual Elements on a Medical Device
US 9,190,010
Cited by 122 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Needleless Connector with Compressible Valve
US 9,144,672
Cited by 62 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 15 fees due Dec 9 to 30, 2026 · next Dec 9
- 17 fees due Jan 2 to 28, 2027 · next Jan 2
- 16 fees due Feb 4 to 28, 2027 · next Feb 4
- 12 fees due Mar 1 to 29, 2027 · next Mar 1
- 25 fees due Apr 1 to 30, 2027 · next Apr 1
- 23 fees due May 3 to 28, 2027 · next May 3
- 12 fees due Jun 3 to 30, 2027 · next Jun 3
- 9 fees due Jul 2 to 30, 2027 · next Jul 2
- 12 fees due Aug 2 to 27, 2027 · next Aug 2
- 7 fees due Sep 1 to 26, 2027 · next Sep 1
- 14 fees due Oct 2 to 30, 2027 · next Oct 2
- 9 fees due Nov 5 to 14, 2027 · next Nov 5
Recent changes
- Oct 13Assignment recorded on 1 record: Workman, Michael K. to CareFusion 303, Inc. Recorded Oct 13, 2026, executed Dec 8, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76354, frame 416.
- Oct 12Assignment recorded on 1 record: Feith, Raymond P. to CareFusion 303, Inc. Recorded Oct 12, 2026, executed Oct 9, 2024. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76342, frame 364.
- 29 of the patents on this record were granted since Aug 18, 2026
- 9 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 452 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| System and Method for Dynamically Adjusting Patient Therapy | 24 in force | to Mar 2035 |
| Collapsible Valve with Internal Dimples | 14 in force | to Jan 2034 |
| Displaying Visual Elements on a Medical Device | 8 in force | to Mar 2032 |
| Method and System for Detecting Location of Fixed Wireless Asset in a Hospital Environment | 7 in force | to Aug 2032 |
| System and Method for Monitoring Progress of Delivery of a Patent-Specific Medication in a Healthcare Facility | 7 in force | to Apr 2032 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,657,443 | Intravenous Medication Harm Index System In force · High confidence | In force | High confidence | |
| US 7,651,481 | Self-Sealing Male Connector Device with Collapsible Body In force · High confidence | In force | High confidence | |
| US 8,060,315 | Method for Measuring the Incidence of Hospital Acquired Infections In force · Medium confidence | In force | Medium confidence | |
| US 7,630,791 | System and Method for Storing Items and Tracking Item Usage In force · High confidence | In force | High confidence | |
| US 7,981,101 | Medical Vial Adapter with Reduced Diameter Cannula and Enlarged Vent Lumen In force · High confidence | In force | High confidence | |
| US 9,358,368 | Catheter Securement Device In force · High confidence | In force | High confidence | |
| US 10,092,729 | Catheter Securement Device In force · High confidence | In force | High confidence | |
| US 8,177,768 | Vial Adapter Having a Needle-Free Valve for Use with Vial Closures of Different Sizes In force · High confidence | In force | High confidence | |
| US 7,766,897 | Protective Priming Cap for Self-Sealing Male Luer Valve In force · High confidence | In force | High confidence | |
| US 11,577,021 | System and Method for Controlling Administration of Medical Fluid In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 881: 28 patents in force now held by others · 148 patents ended · 387 applications pending · 107 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.